AVCTF:OTC-Avacta Group Plc (USD)

COMMON STOCK | Medical Devices | OTC

Last Closing Price

USD 1.36

Change

0.00 (0.00)%

Market Cap

N/A

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

Avacta Group Plc (AVCTF) Stock Analysis:
Based on the Avacta Group Plc stock forecasts from 0 analysts, the average analyst target price for Avacta Group Plc is not available over the next 12 months. Avacta Group Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Avacta Group Plc is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, Avacta Group Plc’s stock price was USD 1.36. Avacta Group Plc’s stock price has changed by +0.00% over the past week, -0.11% over the past month and -6.21% over the last year.

No recent analyst target price found for Avacta Group Plc
No recent average analyst rating found for Avacta Group Plc

About

Currency: USD

Country : GBR

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SEMHF Siemens Healthineers AG

N/A

 USD79.26B 39.40 24.15
SMMNY Siemens Healthineers AG

+0.48 (+1.45%)

 USD76.99B 37.98 24.15
RYLPF Koninklijke Philips N.V

+0.36 (+1.06%)

 USD30.29B 7.25 30.12
SONVF Sonova Holding AG

+0.02 (+0.01%)

 USD21.98B 30.13 22.13
SONVY Sonova Holding AG

+1.21 (+1.73%)

 USD21.85B 30.20 22.13
SNNUF Smith & Nephew plc

N/A

 USD15.66B 28.25 13.97
WILLF Demant A/S

N/A

 USD11.92B 35.40 4.34
GNGBF Getinge AB

+0.37 (+1.03%)

 USD11.74B 16.60 1.74
WILYY Demant A/S

N/A

 USD11.38B 33.62 4.34
GNGBY Getinge AB

+0.15 (+0.41%)

 USD10.14B 16.02 1.74

ETFs Containing AVCTF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.26% 21% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.26% 21% F 16% F
Trailing 12 Months  
Capital Gain -6.21% 60% D- 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.21% 59% F 44% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.26% 25% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.26% 25% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 34.29% 81% B- 62% D-
Risk Adjusted Return 21.17% 33% F 39% F
Market Capitalization N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 0.24 93% A 90% A-
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA -4.60 98% A+ 93% A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.